Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
PAVmed Inc (NASDAQ: PAVM) closed the day trading at $0.36 up 8.69% from the previous closing price of $0.33. In other words, the price has increased by $8.69 from its previous closing price. On the day, 0.15 million shares were traded. PAVM stock price reached its highest trading level at $0.3699 during the session, while it also had its lowest trading level at $0.3404.
Ratios:
For a better understanding of PAVM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.40. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on March 30, 2021, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 05, 2020, Ascendiant Capital Markets started tracking the stock assigning a Buy rating and target price of $5.
On June 28, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.Maxim Group initiated its Buy rating on June 28, 2018, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when JAMES L. COX bought 9,469 shares for $0.78 per share.
JAMES L. COX bought 38,095 shares of PAVM for $32,739 on Dec 09 ’24. On Dec 06 ’24, another insider, JAMES L. COX, who serves as the Director of the company, bought 15,600 shares for $1.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PAVM now has a Market Capitalization of 10069643 and an Enterprise Value of 33273500. For the stock, the TTM Price-to-Sale (P/S) ratio is 358.68 while its Price-to-Book (P/B) ratio in mrq is 0.99. Its current Enterprise Value per Revenue stands at 1147.362 whereas that against EBITDA is -1.661.
Stock Price History:
The Beta on a monthly basis for PAVM is 1.12, which has changed by -0.6556701 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, PAVM has reached a high of $1.25, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -13.83%, while the 200-Day Moving Average is calculated to be -36.57%.
Shares Statistics:
Over the past 3-months, PAVM traded about 504.40K shares per day on average, while over the past 10 days, PAVM traded about 656900 shares per day. A total of 29.67M shares are outstanding, with a floating share count of 24.49M. Insiders hold about 17.46% of the company’s shares, while institutions hold 8.78% stake in the company. Shares short for PAVM as of 1763078400 were 481091 with a Short Ratio of 0.95, compared to 1760486400 on 405577. Therefore, it implies a Short% of Shares Outstanding of 481091 and a Short% of Float of 1.8800000000000001.
